跳至主要内容
临床试验/NCT02566226
NCT02566226已完成4 期

Impact of Intrathecal Morphine on Sleep Apnea Syndrome After Hip Arthroplasty Performed Under Spinal Anaesthesia

Centre Hospitalier Universitaire Vaudois1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2015年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
60
试验地点
1
主要终点
apnea hypopnea index while lying supine

研究概览

简要总结

Intrathecal morphine is commonly used as an analgesic adjunct for hip arthroplasty performed under spinal anaesthesia. Sleep apnea syndrome is a condition that affects up to 10% of the patients. Effect of intrathecal hydrophilic opioids on the frequency and duration of apneic episodes is unknown. The objective of this randomised controlled trial is to investigate the effect of intrathecal morphine and surgery on apneic episodes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • physical status I - III
  • patients scheduled to undergo hip arthroplasty

排除标准

  • planned surgical duration more than 3 hours
  • contraindication to spinal anaesthesia
  • severe respiratory disease
  • patient known and treated for sleep apnea syndrome

研究组 & 干预措施

Bupivacaine with normal saline

Placebo Comparator

干预措施: Bupivacaine with normal saline (Drug)

Bupivacaine with intrathecal morphine

Active Comparator

干预措施: Bupivacaine with intrathecal morphine (Drug)

结局指标

主要结局

apnea hypopnea index while lying supine

时间窗: postoperative night 0

次要结局

  • mean pulse oxymetry(postoperative night 0)
  • Pruritus (yes/no)(postoperative day 0, 1, 2 and 3)
  • apnea hypopnea index while lying in another position than supine(postoperative night 0)
  • Berlin questionnaire(24 h before surgery)
  • STOP-BANG questionnaire(24 h before surgery)
  • Epworth questionnaire(24 h before surgery)
  • postoperative nausea and vomiting (yes/no)(postoperative day 0, 1, 2 and 3)
  • pain scores (numeric rating scale, 0-10)(postoperative day 0, 1, 2 and 3)
  • oxycodone consumption (mg)(postoperative day 0, 1, 2 and 3)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Eric Albrecht

Program Director, Regional Anaesthesia

Centre Hospitalier Universitaire Vaudois

研究点 (1)

Loading locations...

相似试验